Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After Chemotherapy
Status:
Recruiting
Trial end date:
2023-05-10
Target enrollment:
Participant gender:
Summary
The purpose is to evaluate the safety of PEG-rhG-CSF in the prevention of neutropenia in
children with tumor after chemotherapy, and then evaluate the effectiveness of PEG-rhG-CSF in
preventing neutropenia in children with tumor after chemotherapy.